<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Prognostic features of stress testing in patients with known or suspected coronary disease</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Prognostic features of stress testing in patients with known or suspected coronary disease</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Prognostic features of stress testing in patients with known or suspected coronary disease</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Adelaide M Arruda-Olson, MD, PhD, FASE, FAHA, FAMIA</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Panithaya Chareonthaitawee, MD, FACC, FAHA</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">J. Wells Askew, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Mark A Hlatky, MD, FACC, FAHA</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Alan M Garber, MD, PhD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Patricia A Pellikka, MD, FACC, FAHA, FASE</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Juan Carlos Kaski, DSc, MD, DM (Hons), FRCP, FESC, FACC, FAHA</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Todd F Dardas, MD, MS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> May 11, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Stress testing in patients with known or suspected coronary heart disease (CHD) provides information about prognosis as well as diagnosis. This topic will provide an overview of the utility of stress testing for estimation of prognosis as a guide to management in patients with known or suspected CHD. The methodology, indications, and contraindications of stress testing are discussed separately.</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/1494.html" rel="external">"Exercise ECG testing: Performing the test and interpreting the ECG results"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/1534.html" rel="external">"Stress testing for the diagnosis of obstructive coronary heart disease"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/76.html" rel="external">"Risk stratification after non-ST elevation acute coronary syndrome", section on 'Stress testing'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/78.html" rel="external">"Risk stratification after acute ST-elevation myocardial infarction", section on 'Stress testing'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/184.html" rel="external">"Initial evaluation and management of suspected acute coronary syndrome (myocardial infarction, unstable angina) in the emergency department", section on 'Rest and stress imaging studies'</a>.)</p><p></p><p class="headingAnchor" id="H2949813"><span class="h1">INDICATIONS FOR STRESS TESTING FOR PROGNOSIS</span><span class="headingEndMark"> — </span>All indications for performing a stress test for the diagnosis of CHD are also indications for performing a stress test for risk stratification and prognosis. Common indications for performing a stress test include:</p><p class="bulletIndent1"><span class="glyph">●</span>Symptoms suggestive of myocardial ischemia</p><p class="bulletIndent1"><span class="glyph">●</span>Acute chest pain after acute coronary syndrome (ACS) has been excluded</p><p class="bulletIndent1"><span class="glyph">●</span>Recent ACS with no or incomplete revascularization</p><p class="bulletIndent1"><span class="glyph">●</span>Worsening symptoms with known CHD</p><p class="bulletIndent1"><span class="glyph">●</span>Preoperative evaluation for high-risk noncardiac surgery</p><p></p><p>The indications for stress testing are discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/1502.html" rel="external">"Selecting the optimal cardiac stress test", section on 'Indications for stress testing'</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">EXERCISE ECG</span><span class="headingEndMark"> — </span>Exercise stress testing provides more information about prognosis than pharmacologic stress testing. Exercise capacity is one of the strongest determinants of prognosis, and predicts mortality and cardiovascular events, particularly in older adults [<a href="#rid1">1-4</a>]. The heart rate and blood pressure responses to exercise stress also provide prognostic information. Finally, evidence of the presence and extent of stress-induced myocardial ischemia also provides important prognostic information. Among patients who undergo exercise stress, a number of variables, either alone or in combination, are associated with an increased risk of an adverse outcome in patients with CHD [<a href="#rid2">2,5-12</a>]. These include:</p><p class="bulletIndent1"><span class="glyph">●</span>Poor exercise capacity</p><p class="bulletIndent1"><span class="glyph">●</span>Exercise-induced angina, particularly that which is exercise-limiting or occurs at a low workload</p><p class="bulletIndent1"><span class="glyph">●</span>Low peak systolic blood pressure (&lt;130 mmHg) or a fall in systolic blood pressure below baseline during exercise [<a href="#rid12">12</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Low peak heart rate (ie, chronotropic incompetence) (see <a class="local">'Heart rate response to exercise'</a> below)</p><p class="bulletIndent1"><span class="glyph">●</span>Slow recovery of heart rate after exercise</p><p></p><p>There are also a number of ECG findings during exercise that indicate inducible myocardial ischemia and convey a worse prognosis:</p><p class="bulletIndent1"><span class="glyph">●</span>ECG evidence of inducible ischemia (≥1 mm of downsloping or flat ST segment depression during exercise or recovery)</p><p class="bulletIndent1"><span class="glyph">●</span>≥2 mm of ischemic ST depression at a low workload (stage 2 or less or ≤130 beats per minute) </p><p class="bulletIndent1"><span class="glyph">●</span>Early onset (stage 1) or prolonged duration (&gt;5 minutes) of ST depression</p><p class="bulletIndent1"><span class="glyph">●</span>Multiple leads (&gt;5) with ST depression</p><p class="bulletIndent1"><span class="glyph">●</span>ST segment elevation (in leads without pathologic Q waves and not in aVR)</p><p class="bulletIndent1"><span class="glyph">●</span>Ventricular couplets or tachycardia at a low workload or during recovery</p><p></p><p>The prognosis after exercise ECG testing may be better predicted with the use of treadmill scores that take into account multiple variables. (See <a class="local">'Duke treadmill score'</a> below.)</p><p class="headingAnchor" id="H403208476"><span class="h2">Exercise capacity</span><span class="headingEndMark"> — </span>Patients with poor exercise capacity are at increased cardiovascular risk, while those with excellent exercise capacity (a measure of fitness) are at reduced risk [<a href="#rid13">13</a>]. The importance of exercise capacity was illustrated in a report of 6213 consecutive men referred for exercise testing who were then followed for a mean of 6.2 years [<a href="#rid2">2</a>]. After adjustment for age, peak exercise capacity, measured in metabolic equivalents (METs), was the strongest predictor of mortality among men, whether or not they had cardiovascular disease. One MET is defined as the resting oxygen uptake in a sitting position (3.5 mL O<sub>2</sub> uptake/kg per minute), and can be estimated from any of the commonly used exercise protocols. For each 1 MET increase in exercise capacity, there was a 12 percent improvement in survival. The achieved exercise capacity and workload have also been shown to be predictive in older adult populations [<a href="#rid3">3,4</a>].</p><p class="headingAnchor" id="H3"><span class="h2">Flat or downsloping ST depression</span><span class="headingEndMark"> — </span>A positive exercise ECG test is defined as ≥1 mm horizontal (flat) or a downsloping ST segment depression measured at 80 milliseconds after the end of the QRS complex, as recommended by the ACC/AHA guidelines [<a href="#rid14">14</a>]. In addition to providing diagnostic information [<a href="#rid15">15</a>], ST segment depression provides prognostic information, especially when considered in the context of the level of exercise that leads to ST depression. (See  <a class="medical medical_review" href="/d/html/1494.html" rel="external">"Exercise ECG testing: Performing the test and interpreting the ECG results", section on 'ST segment depression'</a>.)</p><p>Flat or downsloping ST depression can occur during exercise and during recovery and has prognostic significance at both time periods.</p><p class="bulletIndent1"><span class="glyph">●</span>In one study of 1472 patients who underwent exercise stress testing and coronary angiography, patients who developed ≥1 mm ST depression in stage 1 or 2 of the Bruce protocol  (<a class="graphic graphic_table graphicRef70044" href="/d/graphic/70044.html" rel="external">table 1</a>) or at heart rates less than 120 beats per minute had a poor prognosis (12-month survival of less than 85 percent) and a high probability of significant left main (25 percent) or three vessel disease (more than 60 percent) [<a href="#rid7">7</a>]. In contrast, the ability to exercise into stage 4 (&gt;10 METs) or to achieve a maximal heart rate greater than 160 beats per minute with &lt;1 mm ST depression was associated with an excellent prognosis (12-month survival more than 99 percent).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Among 4083 medically-treated patients with stable angina enrolled in the Coronary Artery Surgery Study (CASS) Registry, patients with ≥1 mm exercise-induced ST depression and final stage ≤1 of the Bruce protocol  (<a class="graphic graphic_table graphicRef70044" href="/d/graphic/70044.html" rel="external">table 1</a>) were at high risk with an average annual mortality rate of approximately 5 percent per year [<a href="#rid5">5</a>]. In contrast, patients who had &lt;1 mm ST depression and final exercise stage ≥3 on the Bruce protocol were at low risk with an annual mortality of less than 1 percent per year.</p><p></p><p class="headingAnchor" id="H4"><span class="h2">Heart rate response to exercise</span><span class="headingEndMark"> — </span>An impaired heart rate response to exercise, known as chronotropic incompetence, is generally defined as failure to achieve 85 percent of the age-predicted maximum heart rate in the absence of medications known to blunt the heart rate response to exercise (eg, beta blockers or non-dihydropyridine calcium channel blockers). While there are some conflicting data, chronotropic incompetence is generally thought to be predictive of all-cause mortality and CHD risk [<a href="#rid11">11,16-18</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>In a prospective cohort of 2953 patients, 11 percent failed to achieve at least 85 percent of the age-predicted maximal heart rate [<a href="#rid17">17</a>] and had a significant increase in mortality at two years (absolute increase 4 percent, adjusted relative risk [RR] 1.84)  (<a class="graphic graphic_figure graphicRef70339" href="/d/graphic/70339.html" rel="external">figure 1</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Similar findings were noted in a report of 3221 patients undergoing treadmill exercise echocardiography in which 495 patients (15 percent) failed to achieve at least 85 percent of the age-predicted maximal heart rate [<a href="#rid18">18</a>]. At a median follow-up of 3.2 years, these patients had significant increases in all-cause and cardiac mortality compared with patients with &gt;85 percent of age-predicted maximal heart rate (adjusted risk 1.5 and 2.1).</p><p></p><p class="headingAnchor" id="H5"><span class="h2">Heart rate recovery after exercise</span><span class="headingEndMark"> — </span>Delayed return of the heart rate to the normal range after exercise, probably a reflection of decreased vagal reactivation, provides important prognostic information among patients with known CAD as well as among all patients referred for exercise testing. The definitions of abnormal heart rate recovery (HRR) have varied in different studies from ≤12 to ≤18 beats per minute at one minute [<a href="#rid19">19-22</a>] to ≤22 to ≤42 beats per minute at two minutes [<a href="#rid23">23-25</a>]. Late HRR (five minutes after the cessation of exercise) has also been defined and investigated [<a href="#rid26">26</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>In a study of 2428 patients referred for exercise stress testing, abnormal HRR (defined as ≤12 beats per minute) while the patient was exercising lightly during the one minute "cool-down phase" was associated with an increase in overall mortality at six-year follow-up  (<a class="graphic graphic_figure graphicRef57524" href="/d/graphic/57524.html" rel="external">figure 2</a>) [<a href="#rid19">19</a>]. In a follow-up study of 9454 subjects at the same institution, mortality at five years was independently predicted by both abnormal HRR and an intermediate or high Duke treadmill score (8 versus 2 percent in those with a low score) [<a href="#rid20">20</a>]. The predictive value of abnormal HRR was independent of the angiographic severity of coronary disease [<a href="#rid21">21</a>]. (See <a class="local">'Duke treadmill score'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a systematic review which included four studies and 2428 patients with documented pre-existing CAD referred for exercise stress testing, abnormal HRR (defined variably as ≤12 to 21 beats per minute) was associated with greater than fivefold risk of mortality [<a href="#rid27">27</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>In patients who undergo exercise echocardiography requiring them to lie down immediately (rather than having a cool down phase) after exercise cessation, abnormal HRR (≤18 beats per minute) independently predicts increased mortality [<a href="#rid22">22</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Late HRR at five minutes post-exercise appears to provide additional prognostic information beyond that acquired with abnormal HRR at one minute. In a cohort of 2082 patients who underwent exercise testing and were followed for an average of 10 years, patients with impaired late HRR at five minutes had significantly higher all-cause mortality [<a href="#rid26">26</a>].</p><p></p><p class="headingAnchor" id="H126826461"><span class="h2">Exertional hypotension</span><span class="headingEndMark"> — </span>Exertional hypotension, defined as a fall in systolic blood pressure below that measured standing at rest, is fairly rare during exercise testing but when present suggests a poor prognosis, likely due to underlying heart failure or severe multivessel coronary disease [<a href="#rid12">12</a>]. In patients with exercise-induced ischemia or prior myocardial infarction (MI), exertional hypotension is associated with an increased risk for new cardiac events. Other causes of exercise-induced hypotension include fixed cardiac output (as seen with stenotic valvular heart disease or hypertrophic cardiomyopathy), volume depletion, anemia, or certain drugs (such as vasodilators). The exercise test should stop when exertional hypotension is detected.</p><p class="headingAnchor" id="H7"><span class="h2">Ventricular arrhythmias</span></p><p class="headingAnchor" id="H3700498371"><span class="h3">Premature ventricular complexes</span><span class="headingEndMark"> — </span>Exercise-induced ventricular ectopy occurs in 2 to 8 percent of asymptomatic men and women and in 7 to 20 percent of patients undergoing exercise ECG testing for known or suspected coronary disease. Exercise-induced premature ventricular complexes (PVCs) are more common in people with increasing age, male sex, a history of hypertension, and a history of obesity, but are not more frequent in patients with ischemic ST-segment changes [<a href="#rid28">28,29</a>]. </p><p>Exercise-induced PVCs appear to be associated with a worse long-term prognosis. In a meta-analysis of nine studies of over 62,000 people, those with PVCs on stress testing had increased risks for all-cause mortality (RR 1.41, 95% CI 1.23-1.61) and cardiovascular mortality (RR 1.86, 95%CI 1.51-2.30) [<a href="#rid30">30</a>]. </p><p>There are a number of caveats regarding the association of PVCs with cardiovascular mortality:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Occurrence during exercise versus recovery phase </strong>– High-grade PVCs (&gt;10 per minute, couplets, multifocal, R-on-T type, or nonsustained ventricular tachycardia [NSVT]) appear to confer long-term risk of cardiovascular mortality when they occur during the recovery phase but not if they occur only during exercise [<a href="#rid31">31,32</a>]. </p><p></p><p class="bulletIndent1">In an analysis of two studies with relevant data, PVCs during recovery were associated with an increased risk of mortality (RR 1.55, 95% CI 1.22-1.96), and PVCs during exercise were associated with a nonsignificant trend towards greater risk of mortality (RR 1.14, 95% CI 0.96-1.34) [<a href="#rid30">30</a>]. Studies performed in asymptomatic patients have shown similar results [<a href="#rid32">32</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Frequency during exercise </strong>– In observational studies, people with frequent exercise-induced PVCs (eg, defined as ≥2 sequential PVCs, 10 percent during a 30-second recording, multifocal PVCs) have been at higher risk for cardiovascular mortality over the subsequent two decades, with excess adjusted risks ranging from a hazards ratio (HRs) of 1.53 to an RR of 2.5 [<a href="#rid33">33,34</a>].  (<a class="graphic graphic_figure graphicRef64609" href="/d/graphic/64609.html" rel="external">figure 3</a>). </p><p></p><p class="bulletIndent1">Exercise-induced PVCs are related in similar magnitude to all-cause mortality, even when the PVCs occur in relatively low amounts [<a href="#rid28">28</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Known or suspected coronary heart disease </strong>– In patients with known or suspected coronary disease, ventricular ectopy on exercise treadmill stress testing has been associated with higher mortality [<a href="#rid35">35-37</a>]; however, these PVCs were not shown independently to add prognostic information over and beyond the coronary angiogram [<a href="#rid36">36</a>].</p><p></p><p>It remains uncertain whether PVCs during exercise are an independent risk factor or a marker for more severe underlying disease; PCVs may originate from areas of myocardial fibrosis or scarring. The role of myocardial fibrosis was supported by data from 36 athletes referred for cardiac magnetic resonance imaging (CMR) to investigate frequent PVCs. Participants with exercise-induced PVCs were more likely to have cardiac fibrosis on CMR than those with non-exercise-induced PVCs (47 versus 13 percent) [<a href="#rid38">38</a>]. The majority of scarring was in a nonischemic pattern.</p><p class="headingAnchor" id="H346528025"><span class="h3">Nonsustained ventricular tachycardia</span><span class="headingEndMark"> — </span>The occurrence of NSVT during exercise in patients without apparent heart disease does<strong> not</strong> affect long-term prognosis [<a href="#rid39">39-41</a>]. However, the presence of NSVT or high-grade PVCs in the<strong> </strong>recovery phase has been associated with increased risk of cardiovascular mortality [<a href="#rid32">32,33</a>]. The mechanism underlying the increased risk is unclear.</p><p>NSVT was noted in 3.7 percent of 2099 asymptomatic adult volunteers who underwent stress testing in the Baltimore Longitudinal Study of Aging [<a href="#rid42">42</a>]. After multivariable adjustment for age, sex, and coronary risk factors, people with exercise-induced NSVT had no increased risk of mortality over 13.5 years of follow-up (HR 1.30, 95% CI 0.89-1.90). Findings were similar in a separate cohort of over 1300 asymptomatic airmen undergoing occupational exercise stress testing [<a href="#rid43">43</a>]. In this study, exercise-induced NSVT was not associated with an increased incidence of angina pectoris, myocardial infarction, or sudden death over the following six years.</p><p class="headingAnchor" id="H8"><span class="h2">Atrial arrhythmias</span><span class="headingEndMark"> — </span>Atrial arrhythmias also occur during exercise [<a href="#rid44">44,45</a>]. In a report of 5375 patients with known or suspected CHD, premature atrial complexes (also referred to a premature atrial beat, premature supraventricular complex, or premature supraventricular beat) occurred in 24 percent, supraventricular tachycardia in 3.4 percent, and atrial fibrillation/flutter in 0.8 percent [<a href="#rid44">44</a>]. In contrast to exercise-induced ventricular arrhythmias, the development of atrial arrhythmias during exercise was not predictive of long-term rates of cardiac death or revascularization after adjustment for clinical and exercise variables.</p><p class="headingAnchor" id="H9"><span class="h2">Exercise-induced LBBB</span><span class="headingEndMark"> — </span>The development of transient left bundle branch block (LBBB) during exercise testing may also be a marker of increased risk. In a review of 17,277 exercise tests, transient LBBB was noted in 70 (0.4 percent) [<a href="#rid46">46</a>]. The development of LBBB was an independent predictor of death and major cardiac events at four years (adjusted relative risk 2.78).</p><p class="headingAnchor" id="H1050649555"><span class="h1">PROGNOSTIC SCORES</span></p><p class="headingAnchor" id="H693046281"><span class="h2">Duke treadmill score</span><span class="headingEndMark"> — </span>A validated treadmill score from Duke University is based upon data from 2758 consecutive patients seen from 1969 through 1980 with a median age of 49 who had chest pain and underwent both exercise treadmill testing and coronary angiography [<a href="#rid8">8</a>].</p><p>The Duke treadmill score (DTS) is calculated from three exercise parameters, where:</p><p class="bulletIndent1"><span class="glyph">●</span>Exercise time is based on minutes completed on Bruce protocol (or equivalent to Bruce protocol)</p><p class="bulletIndent1"><span class="glyph">●</span>ST deviation is the maximum deviation (in mm) compared with baseline</p><p class="bulletIndent1"><span class="glyph">●</span>Angina score: 0 for no pain, 1 for nonlimiting pain, 2 for exercise limiting pain</p><p></p><div class="formulaContainer"><div class="formula"><p>    DTS = Exercise time (minutes) - (5 x ST deviation) - (4 x angina score)</p></div></div><p>Patients are classified as low, moderate, or high risk according to the score:</p><p class="bulletIndent1"><span class="glyph">●</span>Low risk – score ≥+5</p><p class="bulletIndent1"><span class="glyph">●</span>Moderate risk – score from -10 to +4</p><p class="bulletIndent1"><span class="glyph">●</span>High risk – score ≤-11</p><p></p><p>Subsequent reports have confirmed the utility of the Duke treadmill score in different groups [<a href="#rid47">47-51</a>]. As an example, the following findings were noted in the different risk groups in an analysis of the original Duke cohort of 2758 medically treated patients [<a href="#rid48">48</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Among the 36 percent of patients categorized as low risk, 60 percent had no coronary stenosis ≥75 percent, 16 percent had single vessel disease, and 9 percent had three vessel or left main disease; five-year survival was above 97 percent.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Among the 9 percent of patients categorized as high risk, 74 percent had three vessel or left main disease, and five-year survival was 65 percent.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Among the 55 percent of patients categorized as moderate risk, the frequency of three vessel or left main disease (31 percent) and five-year survival (90 percent) were intermediate between the other two groups.</p><p></p><p>Within each risk class, the prognosis was better in women than men [<a href="#rid49">49</a>]. The Duke treadmill score also appears to perform better in women than men for excluding disease. In a study which included 976 women and 2249 men with chest pain and suspected CHD, fewer low-risk women had any coronary artery with ≥75 percent stenosis (19 versus 47 percent in men) or three vessel or left main disease (3.5 versus 11.4 percent) [<a href="#rid49">49</a>].</p><p>The Duke treadmill score added independent prognostic information to that provided by clinical data, coronary anatomy, and LV function. As an example, subset analysis in the original study revealed that among patients with three-vessel disease, those with an abnormal exercise score had a five-year survival rate of 67 percent compared with 93 percent for those with a normal exercise score [<a href="#rid8">8</a>].</p><p class="headingAnchor" id="H1468864802"><span class="h2">Other risk scores</span><span class="headingEndMark"> — </span>Other treadmill scores have also been devised. One model used exercise testing data from 4083 patients from the Coronary Artery Surgery Study (CASS) registry who were treated medically and followed prospectively [<a href="#rid5">5,52,53</a>]. The presence of significant (≥1 mm) exercise-induced ST depression, the stage of exercise completed, and the extent of LV dysfunction were important determinants of one-year mortality and of the likelihood of three-vessel or left main disease. (See <a class="local">'Flat or downsloping ST depression'</a> above.)</p><p>The Cleveland Clinic nomogram-illustrated model was developed from the results of ECG exercise testing in 30,000 patients referred for suspected coronary heart disease, all of whom had normal baseline ECGs [<a href="#rid53">53</a>]. It was validated in a separate group of over 5000 patients. The Cleveland Clinic model was better able to predict all-cause mortality over three years than the Duke score. However, the Cleveland Clinic model is more difficult to use due to the inclusion of multiple clinical variables such as age, sex, and presence of risk factors, as well as more exercise variables.</p><p class="headingAnchor" id="H403209758"><span class="h1">RADIONUCLIDE MYOCARDIAL PERFUSION IMAGING</span><span class="headingEndMark"> — </span>Combined myocardial perfusion and function results from stress radionuclide myocardial perfusion imaging (rMPI) can distinguish patients at high risk (more than 5 percent annual mortality rate) from those at intermediate risk (1 to 5 percent annual mortality rate) or low risk (less than 1 percent annual mortality rate) [<a href="#rid54">54</a>].</p><p>The prognostic usefulness of pharmacologic stress rMPI is comparable to that of exercise stress rMPI [<a href="#rid1">1,55</a>]. In a meta-analysis that combined data from 14,918 patients in 24 different studies, exercise stress rMPI and pharmacologic stress rMPI were comparable in their ability to risk-stratify patients [<a href="#rid1">1</a>]. The following discussion will include studies of rMPI that involved both exercise stress testing and pharmacologic stress agents.</p><p class="headingAnchor" id="H403209858"><span class="h2">Normal rMPI</span><span class="headingEndMark"> — </span>A normal rMPI has been reported in multiple studies to be associated with low risk of future cardiac events (less than 1 percent per year) [<a href="#rid56">56-64</a>]. As one example of the predictive value of a normal rMPI result, among 5183 consecutive patients with known or suspected CHD who underwent stress rMPI and were followed for an average of 1.8 years, patients with a normal scan (57 percent of patients) had a low risk for cardiac death or MI (≤0.5 and ≤0.3 percent per year, respectively)  (<a class="graphic graphic_figure graphicRef64441" href="/d/graphic/64441.html" rel="external">figure 4</a>) [<a href="#rid56">56</a>].</p><p>The relatively benign prognosis of a normal rMPI scan persists even in patients with a significantly abnormal exercise ECG test or angiographically significant coronary artery disease [<a href="#rid57">57-59,61,65</a>]. In a study of 4649 patients with known or suspected CHD who had an intermediate risk Duke treadmill score (-10 to 4) and a normal or near-normal rMPI, the seven-year survival from cardiovascular death was 99 percent and the seven-year survival from cardiovascular death or MI was 97 percent [<a href="#rid59">59</a>]. (See <a class="local">'Duke treadmill score'</a> above.)</p><p>Patients with known CHD, a high-risk Duke treadmill score, diabetes, chronic kidney disease, and older age have poor outcomes despite a normal scan. The magnitude of these relationships was illustrated in a review of 7376 consecutive patients with a normal exercise or adenosine rMPI [<a href="#rid66">66</a>]. An 80-year-old man with diabetes and known CHD had a relatively high rate of cardiac death or MI at two years (4.9 percent), while a 50-year-old woman without diabetes or known CHD was at minimal risk (0.1 percent).</p><p class="headingAnchor" id="H403210246"><span class="h2">Abnormal rMPI</span><span class="headingEndMark"> — </span>High-risk features on rMPI predicting an increased risk of cardiac events include [<a href="#rid54">54,56,57,67-70</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Extensive ischemia</p><p class="bulletIndent1"><span class="glyph">●</span>Ischemia in more than one coronary artery territory</p><p class="bulletIndent1"><span class="glyph">●</span>Ischemia in multiple segments</p><p class="bulletIndent1"><span class="glyph">●</span>LVEF &lt;45 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Large fixed defects</p><p class="bulletIndent1"><span class="glyph">●</span>Transient or persistent LV cavity dilatation [<a href="#rid71">71,72</a>]</p><p></p><p>As one example of the predictive value of an abnormal rMPI result, among 5183 consecutive patients with known or suspected CHD who underwent stress rMPI and were followed for an average of 1.8 years, patients with normal, mildly abnormal, moderately abnormal, or severely abnormal perfusion defects had progressively higher annual cardiac death rates (0.5, 2.7, 2.9, and 4.2 percent, respectively)  (<a class="graphic graphic_figure graphicRef64441" href="/d/graphic/64441.html" rel="external">figure 4</a>) [<a href="#rid56">56</a>]. Similar findings have subsequently been reported for stress rMPI using <a class="drug drug_general" data-topicid="9462" href="/d/drug information/9462.html" rel="external">regadenoson</a> as the vasodilator [<a href="#rid73">73</a>].</p><p>The risk of an abnormal rMPI varies along with the presence or absence of clinical factors [<a href="#rid60">60,74-76</a>]. In a study that incorporated clinical risk factors (older age, diabetes, resting heart rate, dyspnea as a presenting symptom) and findings on rMPI (percent myocardium that was ischemic), patients with a normal adenosine rMPI had a cardiac mortality rate that varied from 0.4 to 5.3 percent per year in patients with a low and high prognostic score, respectively [<a href="#rid74">74,75</a>]. Similar risk stratification was seen among patients with a moderate to severely abnormal adenosine rMPI, in whom annual cardiac mortality varied from 3.9 to 7.6 percent per year in patients with a low and high prognostic score, respectively. (See <a class="local">'Duke treadmill score'</a> above.)</p><p class="headingAnchor" id="H403211812"><span class="h1">STRESS ECHOCARDIOGRAPHY</span></p><p class="headingAnchor" id="H403211073"><span class="h2">Exercise echocardiography</span><span class="headingEndMark"> — </span>Exercise echocardiography provides independent prognostic information that is incremental to clinical, rest echocardiographic, and exercise ECG characteristics [<a href="#rid77">77</a>]. Of all exercise ECG and exercise echocardiographic variables, exercise capacity (ie, workload) and exercise wall motion score index had the strongest association with outcome, with a direct linear relationship between higher numbers of wall motion abnormalities and adverse cardiac events [<a href="#rid77">77</a>]. The incremental prognostic value of exercise echocardiography has also been demonstrated in older adults (≥65 years of age), in patients with diabetes mellitus, and in patients after coronary artery bypass surgery [<a href="#rid78">78-80</a>]. The predictive value of exercise echocardiography is enhanced by combining echocardiographic findings with other exercise test data [<a href="#rid81">81-83</a>].</p><p>A normal exercise echocardiogram identifies patients at low short-term cardiac risk [<a href="#rid81">81,82,84</a>]. In a report of 1325 patients with a normal stress echocardiogram, the one- and three-year cardiac event-free survival rates were 99 and 97 percent, respectively [<a href="#rid82">82</a>]. Similar findings were noted in a meta-analysis [<a href="#rid84">84</a>]. Event-free survival after a normal exercise echocardiogram in patients with known or suspected CHD was 98 percent at 33 months, with MI or cardiac death of only 0.54 percent per year. In a study of 4004 patients with interpretable ECGs who underwent stress treadmill echocardiography with no chest pain or ischemic ECG changes during the test (ie, normal exercise stress test result), ischemia was identified by echocardiography in 17 percent of patients [<a href="#rid85">85</a>]. The five-year mortality and major cardiac event rates were 6 and 4 percent in patients without ischemia and 12 and 10 percent in those with ischemia.</p><p class="headingAnchor" id="H403211364"><span class="h2">Dobutamine stress echocardiography</span><span class="headingEndMark"> — </span><a class="drug drug_general" data-topicid="9380" href="/d/drug information/9380.html" rel="external">Dobutamine</a> stress echocardiography provides independent prognostic information concerning possible future cardiac events that is incremental to clinical, rest echocardiographic, and exercise ECG characteristics [<a href="#rid83">83,86-96</a>]. The prognosis varies with the presence, severity, and extent of the induced ischemia and the heart rate at onset of myocardial ischemia (or ischemic threshold). Ischemia occurring at less than 60 percent of age-predicted maximal heart rate identified patients at highest risk for postoperative cardiac events.</p><p>In a review of 7333 consecutive patients referred for known or suspected CHD in whom pharmacologic stress echocardiography was performed and follow up to 200 months, overall survival was significantly lower in those with a positive test (59 versus 81 percent), with an estimated mortality of less than 1 percent per year in patients with a negative test [<a href="#rid83">83</a>]. The predictive value was additive to clinical variables and resting echocardiographic wall motion abnormalities.</p><p><a class="drug drug_general" data-topicid="9380" href="/d/drug information/9380.html" rel="external">Dobutamine</a> stress echocardiography is predictive of events in patients with or without resting LV systolic dysfunction [<a href="#rid97">97,98</a>]. ST elevation during dobutamine stress echocardiography has also been associated with a higher risk of future cardiac adverse events [<a href="#rid99">99</a>].</p><p>In a study of 3156 patients who underwent <a class="drug drug_general" data-topicid="9380" href="/d/drug information/9380.html" rel="external">dobutamine</a> stress echocardiography and were followed for up to nine years, the number of abnormal territories at peak stress and the type of wall motion abnormality (ischemia or scar as defined by wall motion abnormalities occurring only during exercise or being present at rest, respectively) were independent predictors of cardiac events  (<a class="graphic graphic_figure graphicRef64154 graphicRef75910" href="/d/graphic/64154.html" rel="external">figure 5A-B</a>) [<a href="#rid90">90</a>].</p><p class="headingAnchor" id="H4056179021"><span class="h2">Combination with Duke treadmill score</span><span class="headingEndMark"> — </span>At a given Duke treadmill score on exercise ECG testing, the prognosis can be further stratified by the findings on concurrently performed exercise echocardiography or radionuclide myocardial perfusion imaging [<a href="#rid59">59,81</a>] and by a clinical determination of risk [<a href="#rid60">60</a>]. (See <a class="local">'Normal rMPI'</a> above.)</p><p>The combined utility of the Duke treadmill score and exercise echocardiography was illustrated in a study of 5375 patients with known or suspected CHD [<a href="#rid81">81</a>]. At a mean follow-up of 5.5 years, the following findings were noted:</p><p class="bulletIndent1"><span class="glyph">●</span>Among patients with a low-risk Duke treadmill score, the yearly mortality in those with a normal rest echocardiographic study, or evidence of disease in a single territory, or in multiple territories, was 0.7, 1.8, and 3 percent, respectively.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Among patients with a moderate-risk Duke treadmill score, the yearly mortality in the three echocardiographic groups was 2.4, 3.7, and 7 percent, respectively.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Among patients with a high-risk Duke treadmill score, the yearly mortality in the three echocardiographic groups was 4.6, 5, and 12 percent, respectively.</p><p></p><p class="headingAnchor" id="H2333251602"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/115939.html" rel="external">"Society guideline links: Chronic coronary syndrome"</a> and  <a class="medical medical_society_guidelines" href="/d/html/119863.html" rel="external">"Society guideline links: Multimodality cardiovascular imaging appropriate use criteria"</a> and  <a class="medical medical_society_guidelines" href="/d/html/122212.html" rel="external">"Society guideline links: Stress testing and cardiopulmonary exercise testing"</a>.)</p><p class="headingAnchor" id="H18"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prognostic role </strong>– Stress testing provides important prognostic information in patients with known or suspected coronary heart disease. (See <a class="local">'Indications for stress testing for prognosis'</a> above and  <a class="medical medical_review" href="/d/html/1502.html" rel="external">"Selecting the optimal cardiac stress test", section on 'Indications for stress testing'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Exercise stress testing provides more information about prognosis than pharmacologic stress testing. Exercise electrocardiogram (ECG) testing is the preferred method of stress testing in most patients. Exercise capacity is one of the most important determinants of prognosis. (See <a class="local">'Exercise capacity'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Exercise-induced ST depression during exercise or recovery also has prognostic significance. (See <a class="local">'Flat or downsloping ST depression'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Arrythmias</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Ventricular arrythmias during the recovery phase of stress testing are associated with worse cardiac outcomes and mortality, whereas less evidence suggests that premature ventricular complexes (PVCs) during exercise are associated with worse outcomes. PVCs in exercise stress testing are associated with a worse long-term prognosis in persons without underlying cardiac disease but do not provide further risk prediction over coronary angiography in persons with known coronary artery disease. (See <a class="local">'Premature ventricular complexes'</a> above.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Nonsustained ventricular tachycardia (NSVT) and atrial arrythmia during exercise are not associated with worse outcomes. (See <a class="local">'Nonsustained ventricular tachycardia'</a> above and <a class="local">'Atrial arrhythmias'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Exercise-induced left bundle branch block may be associated with a worse-outcomes. (See <a class="local">'Exercise-induced LBBB'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Heart rate responses to exercise stress </strong>– This also provides prognostic information, especially if the predicted exercise heart rate cannot be achieved or the heart rate does not promptly recover from peak levels after exercise. (See <a class="local">'Heart rate response to exercise'</a> above and <a class="local">'Heart rate recovery after exercise'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Stress myocardial imaging </strong>– Stress testing with myocardial imaging using either radionuclide perfusion or echocardiography provides incremental prognostic information over clinical characteristics and exercise testing results. (See <a class="local">'Radionuclide myocardial perfusion imaging'</a> above and <a class="local">'Stress echocardiography'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>The Duke treadmill score </strong>– This uses three exercise parameters (exercise time, maximum ST segment deviation, and presence of angina) and is useful for stratifying patients into low-, moderate-, or high-risk categories for future cardiovascular events. (See <a class="local">'Duke treadmill score'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Navare SM, Mather JF, Shaw LJ, et al. Comparison of risk stratification with pharmacologic and exercise stress myocardial perfusion imaging: a meta-analysis. J Nucl Cardiol 2004; 11:551.</a></li><li><a class="nounderline abstract_t">Myers J, Prakash M, Froelicher V, et al. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med 2002; 346:793.</a></li><li><a class="nounderline abstract_t">Goraya TY, Jacobsen SJ, Pellikka PA, et al. Prognostic value of treadmill exercise testing in elderly persons. Ann Intern Med 2000; 132:862.</a></li><li><a class="nounderline abstract_t">Spin JM, Prakash M, Froelicher VF, et al. The prognostic value of exercise testing in elderly men. Am J Med 2002; 112:453.</a></li><li><a class="nounderline abstract_t">Weiner DA, Ryan TJ, McCabe CH, et al. Prognostic importance of a clinical profile and exercise test in medically treated patients with coronary artery disease. J Am Coll Cardiol 1984; 3:772.</a></li><li><a class="nounderline abstract_t">Bruce RA, DeRouen TA, Hammermeister KE. Noninvasive screening criteria for enhanced 4-year survival after aortocoronary bypass surgery. Circulation 1979; 60:638.</a></li><li><a class="nounderline abstract_t">McNeer JF, Margolis JR, Lee KL, et al. The role of the exercise test in the evaluation of patients for ischemic heart disease. Circulation 1978; 57:64.</a></li><li><a class="nounderline abstract_t">Mark DB, Hlatky MA, Harrell FE Jr, et al. Exercise treadmill score for predicting prognosis in coronary artery disease. Ann Intern Med 1987; 106:793.</a></li><li><a class="nounderline abstract_t">Peduzzi P, Hultgren H, Thomsen J, Angell W. Veterans Administration Cooperative Study of medical versus surgical treatment for stable angina--progress report. Section 8. Prognostic value of baseline exercise tests. Prog Cardiovasc Dis 1986; 28:285.</a></li><li><a class="nounderline abstract_t">Forslund L, Hjemdahl P, Held C, et al. Prognostic implications of results from exercise testing in patients with chronic stable angina pectoris treated with metoprolol or verapamil. A report from the Angina Prognosis Study In Stockholm (APSIS). Eur Heart J 2000; 21:901.</a></li><li><a class="nounderline abstract_t">Lauer MS, Okin PM, Larson MG, et al. Impaired heart rate response to graded exercise. Prognostic implications of chronotropic incompetence in the Framingham Heart Study. Circulation 1996; 93:1520.</a></li><li><a class="nounderline abstract_t">Dubach P, Froelicher VF, Klein J, et al. Exercise-induced hypotension in a male population. Criteria, causes, and prognosis. Circulation 1988; 78:1380.</a></li><li><a class="nounderline abstract_t">Hung RK, Al-Mallah MH, McEvoy JW, et al. Prognostic value of exercise capacity in patients with coronary artery disease: the FIT (Henry Ford ExercIse Testing) project. Mayo Clin Proc 2014; 89:1644.</a></li><li><a class="nounderline abstract_t">Gibbons RJ, Balady GJ, Bricker JT, et al. ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). Circulation 2002; 106:1883.</a></li><li><a class="nounderline abstract_t">Gianrossi R, Detrano R, Mulvihill D, et al. Exercise-induced ST depression in the diagnosis of coronary artery disease. A meta-analysis. Circulation 1989; 80:87.</a></li><li><a class="nounderline abstract_t">Lauer MS, Mehta R, Pashkow FJ, et al. Association of chronotropic incompetence with echocardiographic ischemia and prognosis. J Am Coll Cardiol 1998; 32:1280.</a></li><li><a class="nounderline abstract_t">Lauer MS, Francis GS, Okin PM, et al. Impaired chronotropic response to exercise stress testing as a predictor of mortality. JAMA 1999; 281:524.</a></li><li><a class="nounderline abstract_t">Elhendy A, Mahoney DW, Khandheria BK, et al. Prognostic significance of impairment of heart rate response to exercise: impact of left ventricular function and myocardial ischemia. J Am Coll Cardiol 2003; 42:823.</a></li><li><a class="nounderline abstract_t">Cole CR, Blackstone EH, Pashkow FJ, et al. Heart-rate recovery immediately after exercise as a predictor of mortality. N Engl J Med 1999; 341:1351.</a></li><li><a class="nounderline abstract_t">Nishime EO, Cole CR, Blackstone EH, et al. Heart rate recovery and treadmill exercise score as predictors of mortality in patients referred for exercise ECG. JAMA 2000; 284:1392.</a></li><li><a class="nounderline abstract_t">Vivekananthan DP, Blackstone EH, Pothier CE, Lauer MS. Heart rate recovery after exercise is a predictor of mortality, independent of the angiographic severity of coronary disease. J Am Coll Cardiol 2003; 42:831.</a></li><li><a class="nounderline abstract_t">Watanabe J, Thamilarasan M, Blackstone EH, et al. Heart rate recovery immediately after treadmill exercise and left ventricular systolic dysfunction as predictors of mortality: the case of stress echocardiography. Circulation 2001; 104:1911.</a></li><li><a class="nounderline abstract_t">Shetler K, Marcus R, Froelicher VF, et al. Heart rate recovery: validation and methodologic issues. J Am Coll Cardiol 2001; 38:1980.</a></li><li><a class="nounderline abstract_t">Cole CR, Foody JM, Blackstone EH, Lauer MS. Heart rate recovery after submaximal exercise testing as a predictor of mortality in a cardiovascularly healthy cohort. Ann Intern Med 2000; 132:552.</a></li><li><a class="nounderline abstract_t">Mora S, Redberg RF, Sharrett AR, Blumenthal RS. Enhanced risk assessment in asymptomatic individuals with exercise testing and Framingham risk scores. Circulation 2005; 112:1566.</a></li><li><a class="nounderline abstract_t">Johnson NP, Goldberger JJ. Prognostic value of late heart rate recovery after treadmill exercise. Am J Cardiol 2012; 110:45.</a></li><li><a class="nounderline abstract_t">Lachman S, Terbraak MS, Limpens J, et al. The prognostic value of heart rate recovery in patients with coronary artery disease: A systematic review and meta-analysis. Am Heart J 2018; 199:163.</a></li><li><a class="nounderline abstract_t">Morshedi-Meibodi A, Evans JC, Levy D, et al. Clinical correlates and prognostic significance of exercise-induced ventricular premature beats in the community: the Framingham Heart Study. Circulation 2004; 109:2417.</a></li><li><a class="nounderline abstract_t">Sabbag A, Sidi Y, Kivity S, et al. Obesity and exercise-induced ectopic ventricular arrhythmias in apparently healthy middle aged adults. Eur J Prev Cardiol 2016; 23:511.</a></li><li><a class="nounderline abstract_t">Kim J, Kwon M, Chang J, et al. Meta-Analysis of Prognostic Implications of Exercise-Induced Ventricular Premature Complexes in the General Population. Am J Cardiol 2016; 118:725.</a></li><li><a class="nounderline abstract_t">Lee V, Perera D, Lambiase P. Prognostic significance of exercise-induced premature ventricular complexes: a systematic review and meta-analysis of observational studies. Heart Asia 2017; 9:14.</a></li><li><a class="nounderline abstract_t">Refaat MM, Gharios C, Moorthy MV, et al. Exercise-Induced Ventricular Ectopy and Cardiovascular Mortality in Asymptomatic Individuals. J Am Coll Cardiol 2021; 78:2267.</a></li><li><a class="nounderline abstract_t">Jouven X, Zureik M, Desnos M, et al. Long-term outcome in asymptomatic men with exercise-induced premature ventricular depolarizations. N Engl J Med 2000; 343:826.</a></li><li><a class="nounderline abstract_t">Mora S, Redberg RF, Cui Y, et al. Ability of exercise testing to predict cardiovascular and all-cause death in asymptomatic women: a 20-year follow-up of the lipid research clinics prevalence study. JAMA 2003; 290:1600.</a></li><li><a class="nounderline abstract_t">Udall JA, Ellestad MH. Predictive implications of ventricular premature contractions associated with treadmill stress testing. Circulation 1977; 56:985.</a></li><li><a class="nounderline abstract_t">Califf RM, McKinnis RA, McNeer JF, et al. Prognostic value of ventricular arrhythmias associated with treadmill exercise testing in patients studied with cardiac catheterization for suspected ischemic heart disease. J Am Coll Cardiol 1983; 2:1060.</a></li><li><a class="nounderline abstract_t">Frolkis JP, Pothier CE, Blackstone EH, Lauer MS. Frequent ventricular ectopy after exercise as a predictor of death. N Engl J Med 2003; 348:781.</a></li><li><a class="nounderline abstract_t">Cipriani A, Zorzi A, Sarto P, et al. Predictive value of exercise testing in athletes with ventricular ectopy evaluated by cardiac magnetic resonance. Heart Rhythm 2019; 16:239.</a></li><li><a class="nounderline abstract_t">Fleg JL, Lakatta EG. Prevalence and prognosis of exercise-induced nonsustained ventricular tachycardia in apparently healthy volunteers. Am J Cardiol 1984; 54:762.</a></li><li><a class="nounderline abstract_t">Yang JC, Wesley RC Jr, Froelicher VF. Ventricular tachycardia during routine treadmill testing. Risk and prognosis. Arch Intern Med 1991; 151:349.</a></li><li><a class="nounderline abstract_t">Lin D, Callans DJ. Nonsustained VT during exercise testing: causes and work-up. Am Coll Cardiol Curr J Rev 2003; Nov-Dec:57.</a></li><li><a class="nounderline abstract_t">Marine JE, Shetty V, Chow GV, et al. Prevalence and prognostic significance of exercise-induced nonsustained ventricular tachycardia in asymptomatic volunteers: BLSA (Baltimore Longitudinal Study of Aging). J Am Coll Cardiol 2013; 62:595.</a></li><li><a class="nounderline abstract_t">Froelicher VF Jr, Thomas MM, Pillow C, Lancaster MC. Epidemiologic study of asymptomatic men screened by maximal treadmill testing for latent coronary artery disease. Am J Cardiol 1974; 34:770.</a></li><li><a class="nounderline abstract_t">Bunch TJ, Chandrasekaran K, Gersh BJ, et al. The prognostic significance of exercise-induced atrial arrhythmias. J Am Coll Cardiol 2004; 43:1236.</a></li><li><a class="nounderline abstract_t">Jelinek MV, Lown B. Exercise stress testing for exposure of cardiac arrhythmia. Prog Cardiovasc Dis 1974; 16:497.</a></li><li><a class="nounderline abstract_t">Grady TA, Chiu AC, Snader CE, et al. Prognostic significance of exercise-induced left bundle-branch block. JAMA 1998; 279:153.</a></li><li><a class="nounderline abstract_t">Mark DB, Shaw L, Harrell FE Jr, et al. Prognostic value of a treadmill exercise score in outpatients with suspected coronary artery disease. N Engl J Med 1991; 325:849.</a></li><li><a class="nounderline abstract_t">Shaw LJ, Peterson ED, Shaw LK, et al. Use of a prognostic treadmill score in identifying diagnostic coronary disease subgroups. Circulation 1998; 98:1622.</a></li><li><a class="nounderline abstract_t">Alexander KP, Shaw LJ, Shaw LK, et al. Value of exercise treadmill testing in women. J Am Coll Cardiol 1998; 32:1657.</a></li><li><a class="nounderline abstract_t">Kwok JM, Miller TD, Christian TF, et al. Prognostic value of a treadmill exercise score in symptomatic patients with nonspecific ST-T abnormalities on resting ECG. JAMA 1999; 282:1047.</a></li><li><a class="nounderline abstract_t">Koh AS, Gao F, Chin CT, et al. Differential risk reclassification improvement by exercise testing and myocardial perfusion imaging in patients with suspected and known coronary artery disease. J Nucl Cardiol 2016; 23:366.</a></li><li><a class="nounderline abstract_t">Morrow K, Morris CK, Froelicher VF, et al. Prediction of cardiovascular death in men undergoing noninvasive evaluation for coronary artery disease. Ann Intern Med 1993; 118:689.</a></li><li><a class="nounderline abstract_t">Lauer MS, Pothier CE, Magid DJ, et al. An externally validated model for predicting long-term survival after exercise treadmill testing in patients with suspected coronary artery disease and a normal electrocardiogram. Ann Intern Med 2007; 147:821.</a></li><li><a class="nounderline abstract_t">Yao SS, Rozanski A. Principal uses of myocardial perfusion scintigraphy in the management of patients with known or suspected coronary artery disease. Prog Cardiovasc Dis 2001; 43:281.</a></li><li><a class="nounderline abstract_t">Shaw LJ, Iskandrian AE. Prognostic value of gated myocardial perfusion SPECT. J Nucl Cardiol 2004; 11:171.</a></li><li><a class="nounderline abstract_t">Hachamovitch R, Berman DS, Shaw LJ, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction. Circulation 1998; 97:535.</a></li><li><a class="nounderline abstract_t">Vanzetto G, Ormezzano O, Fagret D, et al. Long-term additive prognostic value of thallium-201 myocardial perfusion imaging over clinical and exercise stress test in low to intermediate risk patients : study in 1137 patients with 6-year follow-up. Circulation 1999; 100:1521.</a></li><li><a class="nounderline abstract_t">Brown KA, Rowen M. Prognostic value of a normal exercise myocardial perfusion imaging study in patients with angiographically significant coronary artery disease. Am J Cardiol 1993; 71:865.</a></li><li><a class="nounderline abstract_t">Gibbons RJ, Hodge DO, Berman DS, et al. Long-term outcome of patients with intermediate-risk exercise electrocardiograms who do not have myocardial perfusion defects on radionuclide imaging. Circulation 1999; 100:2140.</a></li><li><a class="nounderline abstract_t">Poornima IG, Miller TD, Christian TF, et al. Utility of myocardial perfusion imaging in patients with low-risk treadmill scores. J Am Coll Cardiol 2004; 43:194.</a></li><li><a class="nounderline abstract_t">Schalet BD, Kegel JG, Heo J, et al. Prognostic implications of normal exercise SPECT thallium images in patients with strongly positive exercise electrocardiograms. Am J Cardiol 1993; 72:1201.</a></li><li><a class="nounderline abstract_t">Raiker K, Sinusas AJ, Wackers FJ, Zaret BL. One-year prognosis of patients with normal planar or single-photon emission computed tomographic technetium 99m-labeled sestamibi exercise imaging. J Nucl Cardiol 1994; 1:449.</a></li><li><a class="nounderline abstract_t">Brown KA. Prognostic value of thallium-201 myocardial perfusion imaging. A diagnostic tool comes of age. Circulation 1991; 83:363.</a></li><li><a class="nounderline abstract_t">Pavin D, Delonca J, Siegenthaler M, et al. Long-term (10 years) prognostic value of a normal thallium-201 myocardial exercise scintigraphy in patients with coronary artery disease documented by angiography. Eur Heart J 1997; 18:69.</a></li><li><a class="nounderline abstract_t">Shaw LJ, Hendel R, Borges-Neto S, et al. Prognostic value of normal exercise and adenosine (99m)Tc-tetrofosmin SPECT imaging: results from the multicenter registry of 4,728 patients. J Nucl Med 2003; 44:134.</a></li><li><a class="nounderline abstract_t">Hachamovitch R, Hayes S, Friedman JD, et al. Determinants of risk and its temporal variation in patients with normal stress myocardial perfusion scans: what is the warranty period of a normal scan? J Am Coll Cardiol 2003; 41:1329.</a></li><li><a class="nounderline abstract_t">McClellan JR, Travin MI, Herman SD, et al. Prognostic importance of scintigraphic left ventricular cavity dilation during intravenous dipyridamole technetium-99m sestamibi myocardial tomographic imaging in predicting coronary events. Am J Cardiol 1997; 79:600.</a></li><li><a class="nounderline abstract_t">Gill JB, Ruddy TD, Newell JB, et al. Prognostic importance of thallium uptake by the lungs during exercise in coronary artery disease. N Engl J Med 1987; 317:1485.</a></li><li><a class="nounderline abstract_t">Nishimura S, Mahmarian JJ, Verani MS. Significance of increased lung thallium uptake during adenosine thallium-201 scintigraphy. J Nucl Med 1992; 33:1600.</a></li><li><a class="nounderline abstract_t">Leslie WD, Tully SA, Yogendran MS, et al. Prognostic value of lung sestamibi uptake in myocardial perfusion imaging of patients with known or suspected coronary artery disease. J Am Coll Cardiol 2005; 45:1676.</a></li><li><a class="nounderline abstract_t">Bajaj NS, Singh S, Farag A, et al. The prognostic value of non-perfusion variables obtained during vasodilator stress myocardial perfusion imaging. J Nucl Cardiol 2016; 23:390.</a></li><li><a class="nounderline abstract_t">Nakanishi R, Gransar H, Slomka P, et al. Predictors of high-risk coronary artery disease in subjects with normal SPECT myocardial perfusion imaging. J Nucl Cardiol 2016; 23:530.</a></li><li><a class="nounderline abstract_t">Hage FG, Ghimire G, Lester D, et al. The prognostic value of regadenoson myocardial perfusion imaging. J Nucl Cardiol 2015; 22:1214.</a></li><li><a class="nounderline abstract_t">Hachamovitch R, Hayes SW, Friedman JD, et al. A prognostic score for prediction of cardiac mortality risk after adenosine stress myocardial perfusion scintigraphy. J Am Coll Cardiol 2005; 45:722.</a></li><li><a class="nounderline abstract_t">Udelson JE, Selker HP. Quantitative instruments for predicting risk ... and benefit. J Am Coll Cardiol 2005; 45:730.</a></li><li><a class="nounderline abstract_t">Veenis JF, Valkema R, van Domburg RT, Schinkel AF. Prediction of 14-year outcomes in patients with a limited exercise capacity: Utility of dobutamine myocardial perfusion imaging in a high-risk population. J Nucl Cardiol 2015; 22:888.</a></li><li><a class="nounderline abstract_t">Arruda-Olson AM, Juracan EM, Mahoney DW, et al. Prognostic value of exercise echocardiography in 5,798 patients: is there a gender difference? J Am Coll Cardiol 2002; 39:625.</a></li><li><a class="nounderline abstract_t">Arruda AM, Das MK, Roger VL, et al. Prognostic value of exercise echocardiography in 2,632 patients &gt; or = 65 years of age. J Am Coll Cardiol 2001; 37:1036.</a></li><li><a class="nounderline abstract_t">Elhendy A, Arruda AM, Mahoney DW, Pellikka PA. Prognostic stratification of diabetic patients by exercise echocardiography. J Am Coll Cardiol 2001; 37:1551.</a></li><li><a class="nounderline abstract_t">Arruda AM, McCully RB, Oh JK, et al. Prognostic value of exercise echocardiography in patients after coronary artery bypass surgery. Am J Cardiol 2001; 87:1069.</a></li><li><a class="nounderline abstract_t">Marwick TH, Case C, Vasey C, et al. Prediction of mortality by exercise echocardiography: a strategy for combination with the duke treadmill score. Circulation 2001; 103:2566.</a></li><li><a class="nounderline abstract_t">McCully RB, Roger VL, Mahoney DW, et al. Outcome after normal exercise echocardiography and predictors of subsequent cardiac events: follow-up of 1,325 patients. J Am Coll Cardiol 1998; 31:144.</a></li><li><a class="nounderline abstract_t">Sicari R, Pasanisi E, Venneri L, et al. Stress echo results predict mortality: a large-scale multicenter prospective international study. J Am Coll Cardiol 2003; 41:589.</a></li><li><a class="nounderline abstract_t">Metz LD, Beattie M, Hom R, et al. The prognostic value of normal exercise myocardial perfusion imaging and exercise echocardiography: a meta-analysis. J Am Coll Cardiol 2007; 49:227.</a></li><li><a class="nounderline abstract_t">Bouzas-Mosquera A, Peteiro J, Alvarez-García N, et al. Prediction of mortality and major cardiac events by exercise echocardiography in patients with normal exercise electrocardiographic testing. J Am Coll Cardiol 2009; 53:1981.</a></li><li><a class="nounderline abstract_t">Marwick T, D'Hondt AM, Baudhuin T, et al. Optimal use of dobutamine stress for the detection and evaluation of coronary artery disease: combination with echocardiography or scintigraphy, or both? J Am Coll Cardiol 1993; 22:159.</a></li><li><a class="nounderline abstract_t">Chuah SC, Pellikka PA, Roger VL, et al. Role of dobutamine stress echocardiography in predicting outcome in 860 patients with known or suspected coronary artery disease. Circulation 1998; 97:1474.</a></li><li><a class="nounderline abstract_t">Cortigiani L, Picano E, Landi P, et al. Value of pharmacologic stress echocardiography in risk stratification of patients with single-vessel disease: a report from the Echo-Persantine and Echo-Dobutamine International Cooperative Studies. J Am Coll Cardiol 1998; 32:69.</a></li><li><a class="nounderline abstract_t">Pingitore A, Picano E, Varga A, et al. Prognostic value of pharmacological stress echocardiography in patients with known or suspected coronary artery disease: a prospective, large-scale, multicenter, head-to-head comparison between dipyridamole and dobutamine test. Echo-Persantine International Cooperative (EPIC) and Echo-Dobutamine International Cooperative (EDIC) Study Groups. J Am Coll Cardiol 1999; 34:1769.</a></li><li><a class="nounderline abstract_t">Marwick TH, Case C, Sawada S, et al. Prediction of mortality using dobutamine echocardiography. J Am Coll Cardiol 2001; 37:754.</a></li><li><a class="nounderline abstract_t">Steinberg EH, Madmon L, Patel CP, et al. Long-term prognostic significance of dobutamine echocardiography in patients with suspected coronary artery disease: results of a 5-year follow-up study. J Am Coll Cardiol 1997; 29:969.</a></li><li><a class="nounderline abstract_t">Marcovitz PA, Shayna V, Horn RA, et al. Value of dobutamine stress echocardiography in determining the prognosis of patients with known or suspected coronary artery disease. Am J Cardiol 1996; 78:404.</a></li><li><a class="nounderline abstract_t">Bigi R, Desideri A, Galati A, et al. Incremental prognostic value of stress echocardiography as an adjunct to exercise electrocardiography after uncomplicated myocardial infarction. Heart 2001; 85:417.</a></li><li><a class="nounderline abstract_t">Krivokapich J, Child JS, Walter DO, Garfinkel A. Prognostic value of dobutamine stress echocardiography in predicting cardiac events in patients with known or suspected coronary artery disease. J Am Coll Cardiol 1999; 33:708.</a></li><li><a class="nounderline abstract_t">Schinkel AF, Bax JJ, Elhendy A, et al. Long-term prognostic value of dobutamine stress echocardiography compared with myocardial perfusion scanning in patients unable to perform exercise tests. Am J Med 2004; 117:1.</a></li><li><a class="nounderline abstract_t">Das MK, Pellikka PA, Mahoney DW, et al. Assessment of cardiac risk before nonvascular surgery: dobutamine stress echocardiography in 530 patients. J Am Coll Cardiol 2000; 35:1647.</a></li><li><a class="nounderline abstract_t">Smart SC, Dionisopoulos PN, Knickelbine TA, et al. Dobutamine-atropine stress echocardiography for risk stratification in patients with chronic left ventricular dysfunction. J Am Coll Cardiol 1999; 33:512.</a></li><li><a class="nounderline abstract_t">Elhendy A, Schinkel AF, Bax JJ, et al. Prognostic value of dobutamine stress echocardiography in patients with normal left ventricular systolic function. J Am Soc Echocardiogr 2004; 17:739.</a></li><li><a class="nounderline abstract_t">Arruda AL, Barretto RB, Shub C, et al. Prognostic significance of ST-segment elevation during dobutamine stress echocardiography. Am Heart J 2006; 151:744.e1.</a></li></ol></div><div id="topicVersionRevision">Topic 1548 Version 37.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15472640" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Comparison of risk stratification with pharmacologic and exercise stress myocardial perfusion imaging: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11893790" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Exercise capacity and mortality among men referred for exercise testing.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10836912" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Prognostic value of treadmill exercise testing in elderly persons.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11959055" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : The prognostic value of exercise testing in elderly men.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6229569" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Prognostic importance of a clinical profile and exercise test in medically treated patients with coronary artery disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/156607" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Noninvasive screening criteria for enhanced 4-year survival after aortocoronary bypass surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/618399" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : The role of the exercise test in the evaluation of patients for ischemic heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3579066" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Exercise treadmill score for predicting prognosis in coronary artery disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3511512" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Veterans Administration Cooperative Study of medical versus surgical treatment for stable angina--progress report. Section 8. Prognostic value of baseline exercise tests.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10806014" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Prognostic implications of results from exercise testing in patients with chronic stable angina pectoris treated with metoprolol or verapamil. A report from the Angina Prognosis Study In Stockholm (APSIS).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8608620" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Impaired heart rate response to graded exercise. Prognostic implications of chronotropic incompetence in the Framingham Heart Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3191592" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Exercise-induced hypotension in a male population. Criteria, causes, and prognosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25440889" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Prognostic value of exercise capacity in patients with coronary artery disease: the FIT (Henry Ford ExercIse Testing) project.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12356646" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2661056" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Exercise-induced ST depression in the diagnosis of coronary artery disease. A meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9809937" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Association of chronotropic incompetence with echocardiographic ischemia and prognosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10022108" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Impaired chronotropic response to exercise stress testing as a predictor of mortality.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12957427" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Prognostic significance of impairment of heart rate response to exercise: impact of left ventricular function and myocardial ischemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10536127" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Heart-rate recovery immediately after exercise as a predictor of mortality.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10989401" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Heart rate recovery and treadmill exercise score as predictors of mortality in patients referred for exercise ECG.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12957428" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Heart rate recovery after exercise is a predictor of mortality, independent of the angiographic severity of coronary disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11602493" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Heart rate recovery immediately after treadmill exercise and left ventricular systolic dysfunction as predictors of mortality: the case of stress echocardiography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11738304" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Heart rate recovery: validation and methodologic issues.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10744592" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Heart rate recovery after submaximal exercise testing as a predictor of mortality in a cardiovascularly healthy cohort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16144993" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Enhanced risk assessment in asymptomatic individuals with exercise testing and Framingham risk scores.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22463837" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Prognostic value of late heart rate recovery after treadmill exercise.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29754656" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : The prognostic value of heart rate recovery in patients with coronary artery disease: A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15148273" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Clinical correlates and prognostic significance of exercise-induced ventricular premature beats in the community: the Framingham Heart Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26069245" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Obesity and exercise-induced ectopic ventricular arrhythmias in apparently healthy middle aged adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27394411" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Meta-Analysis of Prognostic Implications of Exercise-Induced Ventricular Premature Complexes in the General Population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28123456" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Prognostic significance of exercise-induced premature ventricular complexes: a systematic review and meta-analysis of observational studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34857087" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Exercise-Induced Ventricular Ectopy and Cardiovascular Mortality in Asymptomatic Individuals.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10995861" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Long-term outcome in asymptomatic men with exercise-induced premature ventricular depolarizations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14506119" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Ability of exercise testing to predict cardiovascular and all-cause death in asymptomatic women: a 20-year follow-up of the lipid research clinics prevalence study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/923068" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Predictive implications of ventricular premature contractions associated with treadmill stress testing.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6630778" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Prognostic value of ventricular arrhythmias associated with treadmill exercise testing in patients studied with cardiac catheterization for suspected ischemic heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12606732" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Frequent ventricular ectopy after exercise as a predictor of death.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30172028" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Predictive value of exercise testing in athletes with ventricular ectopy evaluated by cardiac magnetic resonance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6486025" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Prevalence and prognosis of exercise-induced nonsustained ventricular tachycardia in apparently healthy volunteers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1992962" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Ventricular tachycardia during routine treadmill testing. Risk and prognosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Nonsustained VT during exercise testing: causes and work-up</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23747767" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Prevalence and prognostic significance of exercise-induced nonsustained ventricular tachycardia in asymptomatic volunteers: BLSA (Baltimore Longitudinal Study of Aging).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4432807" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Epidemiologic study of asymptomatic men screened by maximal treadmill testing for latent coronary artery disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15063436" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : The prognostic significance of exercise-induced atrial arrhythmias.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4590953" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Exercise stress testing for exposure of cardiac arrhythmia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9440667" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Prognostic significance of exercise-induced left bundle-branch block.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1875969" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Prognostic value of a treadmill exercise score in outpatients with suspected coronary artery disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9778327" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Use of a prognostic treadmill score in identifying diagnostic coronary disease subgroups.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9822093" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Value of exercise treadmill testing in women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10493203" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Prognostic value of a treadmill exercise score in symptomatic patients with nonspecific ST-T abnormalities on resting ECG.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26358085" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Differential risk reclassification improvement by exercise testing and myocardial perfusion imaging in patients with suspected and known coronary artery disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8460854" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Prediction of cardiovascular death in men undergoing noninvasive evaluation for coronary artery disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18087052" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : An externally validated model for predicting long-term survival after exercise treadmill testing in patients with suspected coronary artery disease and a normal electrocardiogram.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11235845" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Principal uses of myocardial perfusion scintigraphy in the management of patients with known or suspected coronary artery disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15052249" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Prognostic value of gated myocardial perfusion SPECT.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9494023" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10510055" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Long-term additive prognostic value of thallium-201 myocardial perfusion imaging over clinical and exercise stress test in low to intermediate risk patients : study in 1137 patients with 6-year follow-up.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8456770" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Prognostic value of a normal exercise myocardial perfusion imaging study in patients with angiographically significant coronary artery disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10571972" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Long-term outcome of patients with intermediate-risk exercise electrocardiograms who do not have myocardial perfusion defects on radionuclide imaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14736437" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Utility of myocardial perfusion imaging in patients with low-risk treadmill scores.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8237815" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Prognostic implications of normal exercise SPECT thallium images in patients with strongly positive exercise electrocardiograms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9420729" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : One-year prognosis of patients with normal planar or single-photon emission computed tomographic technetium 99m-labeled sestamibi exercise imaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1991361" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Prognostic value of thallium-201 myocardial perfusion imaging. A diagnostic tool comes of age.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9049517" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Long-term (10 years) prognostic value of a normal thallium-201 myocardial exercise scintigraphy in patients with coronary artery disease documented by angiography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12571200" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Prognostic value of normal exercise and adenosine (99m)Tc-tetrofosmin SPECT imaging: results from the multicenter registry of 4,728 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12706929" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Determinants of risk and its temporal variation in patients with normal stress myocardial perfusion scans: what is the warranty period of a normal scan?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9068516" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Prognostic importance of scintigraphic left ventricular cavity dilation during intravenous dipyridamole technetium-99m sestamibi myocardial tomographic imaging in predicting coronary events.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3683484" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Prognostic importance of thallium uptake by the lungs during exercise in coronary artery disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1517832" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Significance of increased lung thallium uptake during adenosine thallium-201 scintigraphy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15893187" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Prognostic value of lung sestamibi uptake in myocardial perfusion imaging of patients with known or suspected coronary artery disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26940574" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : The prognostic value of non-perfusion variables obtained during vasodilator stress myocardial perfusion imaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25971987" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Predictors of high-risk coronary artery disease in subjects with normal SPECT myocardial perfusion imaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25677160" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : The prognostic value of regadenoson myocardial perfusion imaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15734617" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : A prognostic score for prediction of cardiac mortality risk after adenosine stress myocardial perfusion scintigraphy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15734618" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Quantitative instruments for predicting risk ... and benefit.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25537614" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Prediction of 14-year outcomes in patients with a limited exercise capacity: Utility of dobutamine myocardial perfusion imaging in a high-risk population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11849861" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Prognostic value of exercise echocardiography in 5,798 patients: is there a gender difference?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11263605" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Prognostic value of exercise echocardiography in 2,632 patients&gt;or = 65 years of age.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11345364" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Prognostic stratification of diabetic patients by exercise echocardiography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11348604" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Prognostic value of exercise echocardiography in patients after coronary artery bypass surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11382725" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Prediction of mortality by exercise echocardiography: a strategy for combination with the duke treadmill score.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9426033" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Outcome after normal exercise echocardiography and predictors of subsequent cardiac events: follow-up of 1,325 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12598070" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Stress echo results predict mortality: a large-scale multicenter prospective international study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17222734" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : The prognostic value of normal exercise myocardial perfusion imaging and exercise echocardiography: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19460612" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Prediction of mortality and major cardiac events by exercise echocardiography in patients with normal exercise electrocardiographic testing.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8509537" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Optimal use of dobutamine stress for the detection and evaluation of coronary artery disease: combination with echocardiography or scintigraphy, or both?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9576428" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Role of dobutamine stress echocardiography in predicting outcome in 860 patients with known or suspected coronary artery disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9669251" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Value of pharmacologic stress echocardiography in risk stratification of patients with single-vessel disease: a report from the Echo-Persantine and Echo-Dobutamine International Cooperative Studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10577568" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Prognostic value of pharmacological stress echocardiography in patients with known or suspected coronary artery disease: a prospective, large-scale, multicenter, head-to-head comparison between dipyridamole and dobutamine test. Echo-Persantine International Cooperative (EPIC) and Echo-Dobutamine International Cooperative (EDIC) Study Groups.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11693748" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Prediction of mortality using dobutamine echocardiography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9120183" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Long-term prognostic significance of dobutamine echocardiography in patients with suspected coronary artery disease: results of a 5-year follow-up study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8752183" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Value of dobutamine stress echocardiography in determining the prognosis of patients with known or suspected coronary artery disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11250968" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Incremental prognostic value of stress echocardiography as an adjunct to exercise electrocardiography after uncomplicated myocardial infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10080472" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Prognostic value of dobutamine stress echocardiography in predicting cardiac events in patients with known or suspected coronary artery disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15210381" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Long-term prognostic value of dobutamine stress echocardiography compared with myocardial perfusion scanning in patients unable to perform exercise tests.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10807472" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Assessment of cardiac risk before nonvascular surgery: dobutamine stress echocardiography in 530 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9973033" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Dobutamine-atropine stress echocardiography for risk stratification in patients with chronic left ventricular dysfunction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15220898" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Prognostic value of dobutamine stress echocardiography in patients with normal left ventricular systolic function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16504644" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Prognostic significance of ST-segment elevation during dobutamine stress echocardiography.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
